Global Infection Surveillance Solutions Market

Infection Surveillance Solutions Market Size, Share, Growth Analysis, By Product Type (Software, Services), By End User (Hospitals, Specialty Surgical Centers), By Infection Type (Surgical Site Infections, Blood Stream Infections), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35G2291 | Region: Global | Published Date: October, 2024
Pages: 159 | Tables: 90 | Figures: 68

Infection Surveillance Solutions Market Dynamics

Drivers

Rising Prevalence of Chronic Diseases

  • Chronic disorders like diabetes, cardiovascular disease and metabolic disorders are becoming more prevalent globally. This leads to a rise in hospital stays for a prolonged period. This also increases the risk of infections. In order to efficiently manage and mitigate infection risks, infection surveillance systems must be put in place. It also improves health outcomes and enhances the quality of life.

Increasing Initiatives and Awareness for Infection Control

  • The adoption of surveillance systems is being propelled by a greater understanding among patients and healthcare professionals about the significance of infection prevention and control. The expansion of the market is also aided by several campaigns and efforts launched by health organizations to encourage infection control procedures. This is increasing awareness about infections are the ways to avoid it among patients and hospital workforce.

Restraints

Lack of Education and Awareness

  • Most of the time, medical professionals, patients and caregivers frequently lack awareness about hospital infections. Efficient interaction and education are vital for understanding them and their characteristics. Knowledge about the benefits of infection surveillance systems may be lacking in developing economies. Furthermore, these regions also do not have adequate financial resources, and infrastructure may hinder market expansion. This can massively influence the growth of the market in the region.

Growing Challenges Related to Expense and Reimbursements

  • In most cases, health insurance does not cover infections, and neither are they reimbursed through public healthcare systems in several countries. This lack of reimbursement is becoming a hindrance to patients. To keep infection surveillance systems current and operational, constant maintenance and upkeep are required. Healthcare facilities may find these ongoing expenses burdensome, especially those with limited budgets.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Infection Surveillance Solutions size was valued at USD 213.52 Billion in 2022 and is poised to grow from USD 227.4 Billion in 2023 to USD 376.35 Billion by 2031, growing at a CAGR of 6.5% in the forecast period (2024-2031).

The Infection Surveillance Market is intensely competitive, with businesses constantly engaging in strategic moves, like mergers, acquisitions, and new product launches. It helps them to increase their position in the market. Furthermore, manufacturers are continuously investing in research and development (R&D) activities to enhance the capabilities of their software and hardware. This includes developing advanced analytics, machine learning (ML) algorithms, and predictive modeling to improve infection detection and prevention. In addition, companies are working closely with healthcare facilities to customize their solutions and seamlessly integrate them into existing healthcare IT ecosystems. This ensures that the solutions align with the specific needs and workflows of each organization. 'Baxter International Inc.', 'Becton Dickinson and Company', 'Centrak Inc. (Halma plc)', 'Cerner Corporation', 'CKM Healthcare Incorporated', 'Ecolab Inc.', 'International Business Machines Corporation', 'Medexter Healthcare', 'Perahealth Inc.', 'PointClickCare', 'Premier Inc.', 'Sunquest Information Systems Inc.'

Chronic disorders like diabetes, cardiovascular disease and metabolic disorders are becoming more prevalent globally. This leads to a rise in hospital stays for a prolonged period. This also increases the risk of infections. In order to efficiently manage and mitigate infection risks, infection surveillance systems must be put in place. It also improves health outcomes and enhances the quality of life.

Increasing Rate of Infections Associated with Healthcare (HAIs): Healthcare facilities around the world are extremely concerned about HAIs. It has become a necessity for efficient surveillance systems. These solutions must be able to track, stop, and manage infection outbreaks in hospitals and other healthcare settings. This is fueled by the increasing frequency of infectious illnesses. This factor is increasing opportunities for infection surveillance solutions market in the medical field.

North America is dominating the infection surveillance market with the largest market share. The growth of the segment is mainly due to the rising healthcare infrastructure in countries like the United States and Canada, fueling the demand for infection control surveillance solutions. The increasing expenditure on medical care because of the growing disposable income in the population and the prevalence of chronic disorders are progressing the growth of the market. Furthermore, the increasing prevalence of the hospital acquired infection in the United States are also boosting the demand for the infection control surveillance solutions. These factors are increasing the popularity for infection surveillance solutions resulting in the advancement and expansion of the market in North America.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Infection Surveillance Solutions Market

Report ID: SQMIG35G2291

$5,300
BUY NOW GET FREE SAMPLE